Gildan Activewear Inc.
GILAbout the company
Gildan Activewear Inc. manufactures and sells various apparel products. The company provides various activewear products, including T-shirts, fleece tops and bottoms, sports shirts, polos, and tank tops under Gildan, Hanes, Gildan Performance, Gildan Hammer, Gildan Softstyle, Gildan Heavy Cotton, Gildan Ultra Cotton, Gildan DryBlend, Gildan HeavyBlend, Comfort Colors, American Apparel, ALLPRO, ComfortWash, BEEFY, Bonds and Champion brands.
Investment snapshot
Positive
4
BUY / PASS
Neutral / negative
3 / 8
NEUTRAL / FAIL
Median fair value
$36.12
-15.3% vs price
Models with upside
2 / 16
Positive margin of safety
Strongest signal
7 of 10 pass — Oshaughnessy, Pabrai and Dreman object
Key risk
No clean pass — all 11 investors flag at least one debt & leverage criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
| Metric | O'Shaughnessy Systematic Factor Composite | Lynch GARP | Buffett Quality Compounder | Pabrai Dhandho Framework | Akre Three-Legged Stool | Schloss Asset-Value Discipline | Neff Low-P/E Total Return | Sleep Scale Economies Shared | Templeton Global Bargain Hunter | Marks Risk-Aware Value | Munger Quality Focus | Ackman Activist Value | Dreman Contrarian Value | Piotroski F-Score | Greenblatt Magic Formula | Graham Defensive Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | PASS | FAIL | FAIL | NEUTRAL | FAIL | NEUTRAL | FAIL | FAIL | PASS | NEUTRAL | PASS | PASS | FAIL · Rank #1315 (Top 41%) | FAIL |
| Score | ||||||||||||||||
| Analysis | ||||||||||||||||
| Intrinsic Value | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Margin of Safety | N/A | N/A | +3.3% | -106.3% | +55.7% | N/A | N/A | N/A | -0.8% | -49.8% | -23.9% | -12.6% | -5.2% | N/A | -59.2% | -26.8% |
| Data As Of | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-24) | 10-K (2026-08-24) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) |
Where It Passes
- Cash Flow70% pass✓ 9✗ 3▾
7 of 10 pass — Oshaughnessy, Pabrai and Dreman object
(Operating cash flow - capex) / market capitalization+6.33%; #1199/4487 (top 26.7%)✗OshaughnessyTop 10% of eligible cross-sectionFCF Positive and Growing$499.9M✓LynchPositive and growingFree Cash Flow Proxy$440.0M✓BuffettPositive and growingP/E or FCF YieldP/E=16.3x, FCF Yield=6.3%✗PabraiP/E < 15 or FCF Yield > 10%Operating Cash Flow - Capital Expenditures$499.9M✓Neff> $0 (app proxy for a strong fundamental case)Positive Operating Cash Flow frequency10/10 years positive✓SleepPositive OCF in >= 70% of available yearsFCF Positive10/10 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap6.3%✓Ackman>= 4%Price / FCF per Share15.8x✓Ackman<= 25Price / (CFO / Shares)13.0x✗Dreman< 8xOperating Cash Flow$606.3M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=5.79%, ROA=3.81%✓PiotroskiCFO/Assets > ROA
Where It Falls Short
- Debt & Leverage0% pass✓ 2✗ 12▾
No clean pass — all 11 investors flag at least one debt & leverage criterion
Total Debt / Equity1.21✗Lynch< 0.33Cash - Long-term Debt$-3.6B✗LynchPositive preferredDebt/Equity & Interest CoverageD/E: 1.21, IC: N/A✗BuffettD/E < 0.5 AND Interest Coverage > 5xDebt Levels1.21✗AkreDebt/Equity < 0.3✗MungerDebt/Equity < 0.5Total Debt / Shareholders' Equity1.21x✗SchlossD/E < 1.00x✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗Dreman< 0.8Current Assets / Current Liabilities2.11x✓SchlossCurrent ratio >= 1.50x (app cutoff)✓Dreman> 1.5Interest Coverage & Debt/EBITDAIC=N/A (no interest expense), D/EBITDA=5.6x✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity1.21✗Ackman<= 1.0LT Debt / Total Assets Change33.27% -> 36.92%✗PiotroskiDecreased YoYLT Debt vs Net Current AssetsLT Debt $3.9B vs NCA $2.5B✗GrahamLT Debt <= Net Current Assets - Profitability13% pass✓ 12✗ 19▾
13 of 15 flag GIL's profitability — Oshaughnessy, Lynch, Buffett +10 more
Net income / market capitalization+5.05%; #1566/6251 (top 25.1%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)P/E 16.3x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-4.0%✗Lynch15-30% (Fast Grower); > 0% to passROE11.2%✗Lynch> 15%Net Income Positive (10+ years)9/11 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)25.3%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)17.1% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$440.0M✓BuffettPositive and growingEarnings Variance (10-yr CoV)0.63✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdMargin of SafetyP/E=16.3x, P/B=2.2x✗PabraiP/B < 1.5 or P/E < 15Return on Equity22.0% (3-yr avg)✓AkreROE > 20% (3-year avg)Positive Diluted-EPS Years9/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule)3-5 Year Diluted EPS CAGR-4.0% over 4 years✗Neff7%-20% annualizedRevenue growth vs. gross and operating margin trendgross margin 27.5% -> 31.2%, operating margin 20.1% -> 17.1%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-Year EPS CAGR-4.0% CAGR over 4 years✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend20.1% (2023) -> 17.1% (2025)✗TempletonNon-negative operating-margin trend over 3 yearsDiscount to Intrinsic Value-5.2% (IV=$40.50 vs Price=$42.62)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency9/10 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue17.1%✓Ackman>= 15%Net Income / Shareholders Equity11.2%✗Ackman>= 15%Pre-Tax Income / Revenue13.0%✓Dreman>= 8%Net Income / Shareholders' Equity11.2%✗Dreman> 12%Net Income / Total Assets3.81%✓PiotroskiROA > 0ROA Change YoY10.79% -> 3.81% (delta: -6.98%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=5.79%, ROA=3.81%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY30.7% -> 31.2%✓PiotroskiImproved YoYEBIT / Enterprise Value5.2%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=5.2%, ROC=15.1%✗GreenblattBoth EY > 10% and ROC > 25%Positive EPS (10 years)9/11 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)75.3%✓Graham>= 33% growth - Valuation17% pass✓ 4✗ 22▾
10 of 12 flag GIL's valuation — Oshaughnessy, Lynch, Pabrai +7 more
Revenue / market capitalization+0.4585; #2608/5203 (top 50.1%)✗OshaughnessyTop 10% of eligible cross-sectionNet income / market capitalization+5.05%; #1566/6251 (top 25.1%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+6.33%; #1199/4487 (top 26.7%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-23.41%; #4740/6203 (top 76.4%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)P/E 16.3x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)P/E or FCF YieldP/E=16.3x, FCF Yield=6.3%✗PabraiP/E < 15 or FCF Yield > 10%Price / Book Value per Share2.22x✗SchlossP/B <= 0.80x (app cutoff)✗Templeton< 1.5x✗Dreman< 1.2xPrice / Tangible Book Value per ShareN/A (non-positive TBVPS)✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+144.9%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Price / Diluted EPS16.3x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E-0.14✗Neff> 0.7 (Neff's published traditional edge)Price / EPS16.3x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)✗Dreman< 12xPrice vs. Trailing Low100% of trailing low ($42.62)✓Templeton<= 120% of trailing low (certified split-adjusted live window)P/B or P/E vs. Historical AverageP/E=16.3x, P/B=2.2x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-5.2% (IV=$40.50 vs Price=$42.62)✗Marks>= 20% below intrinsic valueValuation ReasonablenessP/E=16.3x, OE Yield=5.6%✓MungerP/E < 25 or Owner Earnings Yield > 5%Price / FCF per Share15.8x✓Ackman<= 25Price / (CFO / Shares)13.0x✗Dreman< 8xEBIT / Enterprise Value5.2%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=5.2%, ROC=15.1%✗GreenblattBoth EY > 10% and ROC > 25%Price / 3-yr avg EPS15.8x✗Graham<= 15xPrice-to-Book Ratio2.2x✗Graham<= 1.5xP/E x P/B35.00✗Graham<= 22.5 - Valuation models20% pass✓ 2✗ 8▾
Models split on GIL at $42.62 — fair values range $20.66–$96.30
Buffett fair value$44.07✓Buffett+3.3% margin vs $42.62Pabrai fair value$20.66✗Pabrai-106.3% margin vs $42.62Akre fair value$96.30✓Akre+55.7% margin vs $42.62Templeton fair value$42.30✗Templeton-0.8% margin vs $42.62Marks fair value$28.45✗Marks-49.8% margin vs $42.62Munger fair value$34.40✗Munger-23.9% margin vs $42.62Ackman fair value$37.84✗Ackman-12.6% margin vs $42.62Dreman fair value$40.50✗Dreman-5.2% margin vs $42.62Greenblatt fair value$26.77✗Greenblatt-59.2% margin vs $42.62Graham fair value$33.61✗Graham-26.8% margin vs $42.62 - Verdicts31% pass✓ 4✗ 9▾
Split decision: 8 FAIL · 4 PASS · 3 NEUTRAL
Overall verdict✗OshaughnessyFAIL (Rank #902/953 (Top 94.6%))✗LynchFAIL (1/7)✓BuffettPASS (5/9)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)•SchlossNEUTRAL (4/7)✗NeffFAIL (3/6)•SleepNEUTRAL (4/6)✗TempletonFAIL (3/8)✗MarksFAIL (2/5)✓MungerPASS (2/4)•AckmanNEUTRAL (6/9)✓DremanPASS (5/11)✓PiotroskiPASS (F-Score 4)✗GreenblattRank #1315✗GrahamFAIL (3/9) - Growth38% pass✓ 6✗ 7▾
5 of 8 flag GIL's growth — Lynch, Neff, Sleep +2 more
Basic earnings-growth PEG (dividends excluded)P/E 16.3x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR-4.0%✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 113.4% vs Rev: 10.7%✗LynchInventory growth < Revenue growth3-5 Year Diluted EPS CAGR-4.0% over 4 years✗Neff7%-20% annualizedRevenue growth vs. gross and operating margin trendgross margin 27.5% -> 31.2%, operating margin 20.1% -> 17.1%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR12.8%✓SleepCAGR > 7%5-Year EPS CAGR-4.0% CAGR over 4 years✗Templeton> 0% (5-year EPS CAGR)Positive Net Income Frequency9/10 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth2.3%✗Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 yearsEPS Growth Direction$1.47 (2016) -> $2.61 (2025)✓DremanPositive over recent yearsEPS CAGR6.6% CAGR over 9 years✓Dreman> 5% annualizedEPS Growth (3-yr avg, 10-yr window)75.3%✓Graham>= 33% growth - Efficiency50% pass✓ 5✗ 6▾
4 of 8 pass — Akre, Munger, Piotroski +1 more object
ROIC (3-5 yr avg)16.2%✓Buffett> 10%ROIC - WACC+6.2%✓BuffettPositive (WACC = 10%)ROIC (high and growing)FY2023: ROIC=17.3%; FY2024: ROIC=16.3%; FY2025: ROIC=6.2%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC4.1% (RR=66% x ROIC=6.2%)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)4/5 years above 12% (latest 6.2%)✓SleepROIC > 12% in a majority of yearsReturn on Invested Capital6.2%✗Munger> 15%Current Assets / Current Liabilities2.11✓Dreman> 1.5Current Ratio Change YoY2.22 -> 2.11✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.88x -> 0.35x✗PiotroskiImproved YoYEBIT / (NWC + Net Fixed Assets)15.1%✗Greenblatt> 25%Current Ratio2.11✓Graham>= 2.0
Business & financials
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 21.5% of shares last year, 8.9% issued over two.
- Buybacks
- —
- Dividends
- $135.2M
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Annual data (10-K) · Last 5 years
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $7.9B | $7.7Best. | $5.4Best. | $5.3Best. | $7.0Best. |
| Revenue | $3.6B↑11% | $3.3B↑2% | $3.2B↓1% | $3.2B↑11% | $2.9B |
| Operating Income | $619.9M | $618.2M↓4% | $643.9M↑7% | $603.4M↓7% | $651.9M |
| Net Income | $398.9M | $400.9M↓25% | $533.6M↓1% | $541.5M↓11% | $607.2M |
| EPS (Diluted) | $2.61↑6% | $2.46↓19% | $3.03↑3% | $2.93↓5% | $3.07 |
| Gross Margin | 31.2%↑2% | 30.7%↑11% | 27.5%↓10% | 30.6%↓5% | 32.2% |
| Operating Margin | 17.1%↓9% | 18.9%↓6% | 20.1%↑8% | 18.6%↓17% | 22.3% |
| ROE | 11.2%↓59% | 27.5%↑1% | 27.3%↓5% | 28.8%↓9% | 31.6% |
| Total Debt | $4.3B↑181% | $1.5B↑56% | $985.0M↑6% | $930.0M↑55% | $600.0M |
| Shareholders' Equity | $3.6B↑145% | $1.5B↓26% | $2.0B↑4% | $1.9B↓2% | $1.9B |
| Current Ratio | 2.11↓5% | 2.22↓5% | 2.33↓13% | 2.69↓14% | 3.12 |
| Debt / Equity | 1.21↑15% | 1.05↑110% | 0.50↑2% | 0.49↑58% | 0.31 |
| Operating Cash Flow | $606.3M↑21% | $501.4M↓8% | $546.6M↑32% | $413.5M↓33% | $617.5M |
| Free Cash Flow | $499.9M↑40% | $356.1M↑4% | $343.3M↑97% | $174.4M↓64% | $490.1M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Apparel
GIL vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CINTAS CORPCTAS | $79.0B | $197.74 | $10.3B | $1.8B | 38.7% | 0.52 | 22.8% | 2.09 | 3/9 | 5/9 | 1/7 | 1/3 | F-Score 5 | 5/11 |
| TAPESTRY, INC.TPR | $22.8B | $114.12 | $7.0B | $183.2M | 21.4% | 2.79 | 5.9% | 1.87 | 1/9 | 3/9 | 1/7 | 0/3 | F-Score 5 | 3/11 |
| Amer Sports, Inc.AS | $15.2B | $27.24 | $6.6B | $427.4M | 7.4% | 0.14 | 10.7% | 1.50 | 2/9 | 3/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| DECKERS OUTDOOR CORPDECK | $10.8B | $77.68 | $5.5B | $1.0B | 41.0% | — | 23.1% | 3.54 | 2/9 | 5/9 | 3/7 | 3/3 | F-Score 7 | 5/11 |
| lululemon athletica inc.LULU | $10.7B | $96.87 | $11.1B | $1.6B | 31.8% | 0.00 | 19.9% | 2.26 | 4/9 | 5/9 | 3/7 | 3/3 | F-Score 4 | 5/11 |
| On Holding AGONON | $9.9B | $29.55 | $3.8B | $257.3M | 12.5% | 0.32 | 12.5% | 2.71 | 2/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| LEVI STRAUSS & COLEVI | $7.6B | $19.75 | $6.3B | $578.1M | 25.4% | 0.46 | 10.8% | 1.55 | 3/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 5/11 |
| Crocs, Inc.CROX | $6.3B | $126.14 | $4.0B | $81.2M | -6.3% | 0.95 | 3.7% | 1.27 | 2/9 | 4/9 | 0/7 | 1/3 | F-Score 5 | 2/11 |